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Primary infection of macaques with pathogenic isolates of simian immunodeficiency virus (SIV) (as a model of HIV infection
in humans) represents a unique opportunity to study early lentivirus/host interactions. We sought to determine whether there
is a temporal relationship linking SIV replication and dissemination and the expression of the chemokine RANTES (regulated
upon activation normal T cell expressed and secreted) and the SIV/HIV coreceptor CCR5 in different tissues during acute SIV
infection of macaques. Four cynomolgus macaques were inoculated intravenously with a pathogenic primary isolate of
SIVmac251. RT-PCR was used to monitor the expression of RANTES and CCR5 mRNA in fresh isolated mononuclear cells
from blood, lymph node, and bronchoalveolar lavages. These expressions were compared to those of IFN-g as an indicator
of the development of the immune response and to another receptor for RANTES, CCR1, which is not described as a
coreceptor for SIV/HIV-1 entry. An enhancement of CCR1/CCR5 mRNA expression was noticed during primary SIVmac251
infection of macaques, mainly in tissue. In the three different compartments investigated, IFN-g and RANTES overexpression
was noticed by the time of systemic viral replication containment. Our results put CCR5 and RANTES mRNA expression back
in the context of inflammatory and immune responses to SIV primary infection. © 1999 Academic Press
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Chemokines are a large family of proteins involved in
he recruitment and activation of several cell types. They
nduce their biological effects by interacting with specific
eceptors on the surface of target cells (Baggiolini et al.,
997; Luster, 1998). Interestingly, CC chemokines MIP-1a
macrophage inflammatory protein), MIP-1b, and RAN-
ES (regulated upon activation normal T cell expressed
nd secreted) are able to suppress the replication of
acrophage tropic HIV strains in vitro (Cocchi et al.,
995). Their suppressive effects are likely due to the
nhibition of the coreceptor function for viral entry of their
atural shared receptor: the CC chemokine receptor 5
CCR5) (Doms and Peiper, 1997). The finding that the D32
utation on the ccr5 allele, leading to a truncated
olypeptide that is not expressed on the cell surface,
onfers to exposed individuals a significant degree of
esistance to HIV-1 infection stresses the major role of
CR5 as coreceptor for HIV-1 in vivo (Doms and Peiper,
997). In vitro, RANTES is consistently the most effective
IV suppressor (Cocchi et al., 1995). However, the clini-
al relevance of this chemokine is still debated. RANTES
1 To whom correspondence and reprint requests should be ad-
ressed at Service de Neurovirologie, DSV/DRM, Commissariat a`
’Energie Atomique, B.P. 6, 92265 Fontenay aux Roses, Cedex, France.
iax: 133 1 46 54 77 26. E-mail: legrand@dsvidf.cea.fr.
285nd CCR5 interactions during HIV infection are not lim-
ted to their potential to control viral replication: RANTES
s an important inflammatory mediator. RANTES is impli-
ated in the migration of several leukocytes in different
issues (Baggiolini et al., 1997) and may participate in the
xtent and/or the nature of the immune response (Chen-
ue et al., 1997; Dairaghi et al., 1998; Taub et al., 1996). It
s thus difficult to predict how this chemokine influences
IV infection in a complex physiological environment.
Primary HIV infection is characterized by high levels of
iral replication followed by the containment of virus
pread, suggesting an early efficient immune control
Daar et al., 1991). This period represents therefore a
nique opportunity to investigate RANTES/CCR5 interac-
ions with virus replication in vivo. For this purpose sim-
an immunodeficiency virus (SIV) infection of macaques
ppears very attractive. SIVs are nonhuman primate len-
iviruses that share genomic organization and biological
roperties with HIV-1 and HIV-2. Some SIV strains, like
IVmac, induce AIDS in macaques (Daniel et al., 1985;
esrosiers, 1990). Moreover, SIVmac and monocyte/
acrophage tropic strains of HIV-1 that predominate
arly after infection share CCR5 as coreceptor of the
olecule CD4 for entry in target cells (Berger et al., 1998;
hen et al., 1997; Marcon et al., 1997) and MIP-1a,
IP-1b, and RANTES inhibit SIV infection in vitro (Cocchi
t al., 1995; Wang et al., 1998). More recent findings
ndicate that additional chemokine receptors or related
0042-6822/99 $30.00
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286 CHE´RET ET AL.even-transmembrane segment receptors can function
s SIV coreceptors (Hoffman and Doms, 1998).
In the present work, we sought to determine whether
here is a temporal relationship linking SIV infection and
he expression of RANTES and CCR5 in different tissues
uring acute SIV infection of macaques. These expres-
ions were compared to those of IFN-g as an indicator of
he development of the immune response and another
eceptor for RANTES, CCR1. CCR1 is not a coreceptor for
IV/HIV-1 entry; however, it is expressed on monocytes
nd lymphocytes, the main target of HIV/SIV as CCR5
Rottman et al., 1997; Su et al., 1996). Consequently, we
nvestigated the expression of transcripts of RANTES,
FN-g, CCR1, and CCR5 in peripheral blood mononuclear
ells (PBMC), lymph node mononuclear cells (LNMC),
nd mononuclear cells obtained after bronchoalveolar
avage (BALMC) during acute infection of macaques with
pathogenic primary isolate of SIVmac251. These anal-
ses were performed in parallel with the evaluation of
ystemic virus load and T lymphocyte subset changes.
RESULTS
linical follow-up
Starting on day 7 after SIV inoculation, all four animals
eveloped a generalized lymphadenopathy. Peripheral
ymphadenopathy, characterized by increases in all lym-
hocyte subsets within lymph nodes, is an early and
ustained symptom following virus infection (Reimann et
l., 1994).
ystemic virological and immunological follow-up
All four animals inoculated with the primary isolate of
IVmac251 became infected. Levels of SIV RNA in
lasma peaked between days 12 and 19 postinoculation
p.i.) (Fig. 1A). By this time, plasma associated virus load
as the lowest for monkey J122 (Fig. 1A). Circulating
nfectious cells were detected by the first week p.i. in the
lood of monkey J495 and by the second week p.i. for the
ther animals: the highest titer was measured for mon-
ey J495 by day 14 p.i. and monkey J122 was once again
he animal with the lowest titer (Fig. 1B). Titers at day
1 p.i. are ,1, which is the limit of detection for this
ssay. Using more sensitive, but not quantitative, meth-
ds, it was possible to isolate virus from blood cells at
his time (data not shown).
Infection of PBMC, LNMC, and BALMC was confirmed
y PCR analysis for the four animals by day 14 p.i. (data
ot shown). In BALMC proviral DNA remained detectable
or monkeys J116, J418, and J495 throughout the study,
xcept for monkey J122, the animal with the lowest sys-
emic virus load (data not shown). The animals serocon-
erted by day 21 p.i. (Fig. 1C). ohanges in T lymphocyte subsets
Statistically significant decreases in circulating CD41
nd CD81 lymphocyte counts were observed on day
4 p.i. (P , 0.06) for monkeys J116, J418, and J495 (Fig. 2).
t this time point, no statistically significant changes in
irculating CD41 and CD81 lymphocyte counts were
bserved for monkey J122, the animal with the lowest
ystemic virus load. After day 21 p.i., monkey J116 dem-
nstrated an increase in CD81 lymphocyte counts above
reinoculation values. In lymph nodes, a modest down-
ard trend of the percentage of CD41 lymphocytes was
bserved from day 7 for the four monkeys (Fig. 2). The
ercentage of CD81 lymphocytes remained stable for
hree monkeys (J116, J122, and J495). A rise of the per-
entage of CD81 lymphocytes was observed by day 7 for
FIG. 1. Systemic parameters. (A) Viral plasma mRNA (copies/ml). (B)
lood cell associated virus load titer (TCID50). (C) SIV antibodies (op-
ical density).ne animal (J418). Since lymphadenopathy was evident
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287RANTES AND CCR5 EXPRESSION DURING ACUTE SIV INFECTIONn these four animals, stable or weak changes in the
ercentages of CD41 or CD81 cells probably corre-
pond to an absolute increase in those subsets in the
eripheral lymph nodes. To assess T lymphocyte
hanges in the lung of macaques acutely infected with
IV, bronchoalveolar lavage (BAL) was performed. The
ercentage of BAL fluid recovered was approximately
5% of the injected fluid. The alveolar cellularity ranged
rom 50,000 to 200,000 cells per milliliter of fluid recov-
red. No statistically significant difference in cellularity
as noticed between baseline and postinfection BAL
data not shown). To rule out potential side effects of
epeated bronchoalveolar lavages, we have verified that
epeated bronchoalveolar lavages in uninfected animals
o not affect the percentages of CD81 and CD41 lym-
hocytes among BALMC even if weekly bronchoalveolar
avages were followed by two lavages a week (Che´ret et
l., 1996) (data not shown). During the course of this
tudy, the majority of BALMC recovered were macro-
hages (greater than 85%). Percentages of CD41 lym-
hocytes among BALMC remained low for all the mon-
eys during acute SIV infection (below 2.5%) (Fig. 2). A
ignificant enhancement of the percentage of CD81 lym-
hocytes among BALMC was detected for the four mon-
eys, but it differed from one animal to another (Fig. 2).
he percentage of CD81 lymphocytes increased sub-
tantially in the mononuclear cell population for monkeys
116, J495, and J418 by day 17 or 21 p.i. (Fig. 2). For these
nimals, 3 weeks after SIV inoculation, the majority of
AL lymphocytes were of the CD81 phenotype (up to
0%). Animal J122, which exhibited the lowest circulating
nfectious cell titers and SIV RNA plasma levels, pre-
ented only a weak increase of CD81 percentage on day
1
FIG. 2. Changes in T lymphocyte subsets. Numbers of circulating CD
n LNMC; percentages of CD41 and CD81 T lymphocytes among BAL5 p.i. Therefore, enhancement of CD8 in BAL appears fo be correlated with systemic viral load as we previously
uspected (Che´ret et al., 1996).
inetics of RANTES, CCR5, CCR1, and IFN-g mRNA
xpression
Data from the blood compartment may not accurately
eflect events in lymphoid organs. Consequently, to in-
estigate chemokine or chemokine receptor mRNA ex-
ression, our study was performed concomitantly on
BMC, LNMC, and BALMC. To prevent interindividual
ariations in the number of mRNA copies, we chose to
ompare each animal before and after inoculation, in-
tead of comparing groups of uninfected and infected
nimals. From day 7 p.i. to day 35 p.i., significant en-
ancement of CCR5 mRNA expression was detected in
ALMC in four of four animals and in PBMC in two of four
onkeys. In LNMC, three of four monkeys exhibited a
CR5 mRNA overexpression (Table 1). During this same
eriod of active viral replication, enhancement of CCR1
RNA expression was detected in BALMC of the four
nimals (although it was statistically significant in only
hree of four) and in PBMC in two of the animals (Table
). CCR1 mRNA expression in LNMC of monkey J122
eaked on day 14 p.i. (day 0 p.i., CCR1 mRNA/GAPDH
RNA ,0.1; day 14 p.i., CCR1 mRNA/GAPDH mRNA 5
.2; data not shown). We have previously described that
significant increase of IFN-g mRNA expression oc-
urred in BALMC during acute SIVmac251 infection
Che´ret et al., 1996). As expected, we confirmed a signif-
cant enhancement of IFN-g mRNA in BALMC of the four
onkeys (Fig. 3). An increased expression of IFN-g
RNA was also noticed in LNMC during acute SIV in-
CD81 T lymphocytes; percentages of CD41 and CD81 T lymphocytes41 andection as previously described (Zou et al., 1997). Statis-
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288 CHE´RET ET AL.ically significant changes in IFN-g mRNA expression
ere detected in PBMC of two of the animals (Fig. 3).
FN-g mRNA levels were undetectable in the PBMC of
onkey J122 before infection and weakly detectable after
IV infection (Benveniste et al., 1996). Closely related to
FN-g mRNA profiles, a statistically significant increased
xpression of RANTES mRNA was observed in BALMC
n the four animals and in LNMC and PBMC in three
nimals (Fig. 3). These results emphasize the importance
f a comparative study of immunological parameters in
ifferent tissues. As we previously reported (Che´ret et al.,
996, 1997), the blood compartment may not accurately
eflect pathogenetic events that occur in lymphoid or-
ans. IFN-g and RANTES overexpression was noticed in
ifferent tissues from the third week of infection on by
he time of containment of virus replication as assessed
y plasma SIV RNA quantification; these overexpres-
ions occurred earlier in BALMC than in PBMC. In-
reased IFN-g and RANTES expression closely paral-
T
CCR5 mRNA Levels (as a Ratio
Monkey: J116 J122
PBMC LNMC BALMC PBMC LNMC
Preinoculation: 0.1 0.8 0.2 0.1 1.2
n: 5 1 5 5 1
SD: 60.2 60.2 60.2
ays p.i.
7 0.6 0.4 0.5 ,0.1 2.0
14 ,0.1 0.1 0.3 1.1 3.0
21 2.9 1 ,0.1
28 0.7 0.8 0.5
35 0.5 1.3 0.1 0.1 1.4
Note. Values in boldface type: P , 0.05 (receptor GAPDH ratio o
reinoculation values represent the average of (n) time points tested b
T
CCR1 mRNA Levels (as a Ratio
Monkey: J116 J12
PBMC BALMC PBMC
Preinoculation: 0.8 0.3 1.2
n: 5 5 5
SD: 61.1 60.2 60.6
ays p.i.
7 1.4 0.5 2.6
14 ,0.1 0.6 5.4
21 2.1 1.2 2.8
28 0.6 1.3 2.8
35 3.6 0.5 5.3
Note. Values in boldface type: P , 0.05 (receptor GAPDH ratio o
reinoculation values represent the average of (n) time points tested before Seled a marked increase in the percentages of CD81 T
ymphocytes in BALMC.
DISCUSSION
Acute infection of macaques with pathogenic isolates
f SIV as a model of HIV infection of humans represents
unique opportunity to study early lentivirus/host inter-
ctions (Benveniste et al., 1996; Lifson et al., 1997). In-
ection of macaques with the macrophage tropic SIV-
ac251 permits simultaneous experimental investiga-
ions not only at the systemic level but also locally in
ach of the target organs of lentiviruses. This seems
articularly relevant in the study of the in vivo role of
ytokines and chemokines, which are likely to contribute
o HIV control and/or pathogenesis by autocrine and/or
aracrine interactions. To clarify the involvement of the
hemokine RANTES and its receptor CCR5 in the early
ontrol of viral replication as well as their contribution to
ceptor mRNA/GAPDH mRNA)
J418 J495
MC PBMC LNMC BALMC PBMC LNMC BALMC
.1 0.6 ,0.1 0.5 1.0 0.8 0.2
2 1 5 5 1 5
.0 60.6 60.4 60.6 60.2
.5 0.4 ,0.1 0.9 1.1 0.1 0.5
.1 ,0.1 1.0 1.4 NT NT 1.5
.1 0.4 0.8 1.1 1.0
.1 0.8 2.5 3.0 0.5
.7 1.0 1.2 1.9 1.6 2.3 0.3
7, 14, 21, 28, and 35 p.i. were compared to preinoculation values);
IV inoculation. NT, not tested.
ceptor mRNA/GAPDH mRNA)
J418 J495
MC PBMC BALMC PBMC BALMC
.6 ,0.1 ,0.1 0.6 1.1
2 5 5 5
.3 60.0 60.1 60.5 60.5
.0 0.4 0.1 0.9 0.1
.0 1.1 0.7 NT 1.5
.9 0.7 ,0.1 ,0.1 0.6
.8 0.9 0.3 0.7 1.3
.2 1.6 ,0.1 2.5 1.3
7, 14, 21, 28, and 35 p.i. were compared to preinoculation values);ABLE 1
of Re
BAL
,0
5
60
0
,0
,0
,0
1
n daysABLE 2
of Re
2
BAL
1
5
60
1
2
0
0
1
n days
IV inoculation. NT, not tested.
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289RANTES AND CCR5 EXPRESSION DURING ACUTE SIV INFECTIONmmunological or inflammatory processes during acute
IV infection, we simultaneously investigated the early
vents taking place in the lung, lymph node, and blood of
acaques inoculated intravenously with a pathogenic
solate of SIVmac251. We demonstrated that primary in-
ection is characterized by an enhancement of CCR1/
CR5 mRNA expression in BALMC, LNMC, and to a
esser extent in PBMC. IFN-g and RANTES mRNA levels
ncreased at late times after infection in these different
ompartments by the time of the containment of systemic
iral load. This study highlights the particular interest of
tudying peripheral lymphoid organs to investigate che-
okine and chemokine receptor expression.
The increase in the percentage of CD81 T cells in
ifferent tissues that we and others have observed dur-
ng acute SIV infection by the time of seroconversion is
ess marked in PBMC and LNMC than in BALMC. It
ndicates the early recruitment of immunocompetent
ells to the tissular compartment during primary lentivi-
us infection (Che´ret et al., 1996; Reimann et al., 1994;
osenberg et al., 1997). Mechanisms that cause trans-
ascular migration of leukocytes in specific tissues dur-
ng SIV/HIV infection are not well understood. High levels
f cytokines in plasma (Rosenberg et al., 1997) and
nduction of adhesion molecules on the leukocyte sur-
ace (Birdsall et al., 1997) have been implicated, suggest-
ng a major role played by chemokines and their G-
rotein-coupled receptors (Baggiolini et al., 1997). In our
xperiment, from day 7 p.i. to day 35 p.i., we observed a
ignificant overexpression of CCR1 and CCR5 mRNA.
oth these chemokine receptors are expressed on
onocytes, CD81 and CD41 lymphocytes (Rottman et
FIG. 3. IFN-g and RANTES mRNA levels (as a ratio of cytokine mRN
4, 17, 21, 28, and 35 were compared to preinoculation values). Pre
noculation.l., 1997; Wu et al., 1996; Wu et al., 1997b). The levels and ainetics of CCR5 mRNA varied among animals, the com-
artment investigated, and time points.
The wide range of variability of CCR5 cell surface
xpression is well documented among humans (Os-
rowski et al., 1998; Wu et al., 1997b). It is of concern that
RNA levels may not totally reflect protein synthesis,
xcretion, or surface expression. However, Moriuchi et
l. (1997a) recently reported the link between up-regula-
ion of the CCR5 promoter and cell surface expression of
he molecule. Furthermore, leukocyte responses to che-
okines are known to correlate with their receptor
RNA expression (Loetscher et al., 1996). Interestingly,
CR5 is expressed in a cell subset thought to represent
reviously activated/memory T cells, which exhibit the
ighest transendothelial chemotactic potential (Bleul et
l., 1997; Loetscher et al., 1996). The CCR mRNA overex-
ression that we detected mainly in LNMC and BALMC
ay strengthen the hypothesis that during SIV primary
nfection, by up-regulating CCR, immune cells migrate
nto infected tissue compartments. Our results confirm
nd extend previous data suggesting the recruitment of
CR51 cells to inflammatory sites and the early activat-
d/memory state of immune T cells during HIV/SIV in-
ection (Cossarizza et al., 1995; Qin et al., 1998; Reimann
t al., 1994; Rottman et al., 1997). The molecular events
esponsible for increased mRNA expression of CCR5
hat we detected during primary infection are unknown. It
s unlikely that CCR5 mRNA overexpression is exclu-
ively related to intense SIV replication, since statistically
ignificant values have been noticed as soon as day
p.i. before peaks of systemic viral load or at late times
f infection after the apparent control of replication. Vari-
H mRNA). *P , 0.05 (cytokine mRNA/GAPDH mRNA ratio on days 7,
tion value represents the average of time points tested before SIVA/GAPD
inoculation among time points highlights the complexity of
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290 CHE´RET ET AL.hemokine receptor expression regulation. Neverthe-
ess, changes in CCR5 levels may not be linked to the
coreceptor function” of CCR5 since mRNA expression of
CR1, a receptor not used for SIV entry, was also in-
reased during acute SIV infection. Taken together,
CR1 and CCR5 mRNA overexpression strengthens the
ypothesis that, as early as primary infection, perturba-
ions of chemokine receptor expression take place in an
nflammatory and immune network (Gerard et al., 1997;
strowski et al., 1998). We and others have already
emonstrated that primary SIV infection of macaques is
haracterized by an increased production of proinflam-
atory mediators (Che´ret et al., 1996, 1997; Zou et al.,
997). In addition, CCR5 is a coreceptor for SIV/HIV entry
Chen et al., 1997; Marcon et al., 1997) and its overex-
ression may therefore illustrate an increased suscepti-
ility to infection of monocytes and CD41 T lymphocytes
nd facilitate tissue dissemination of infected cells (Rott-
an et al., 1997; Wu et al., 1997b). This close relationship
etween viral infection and dissemination is strength-
ned by the observation that CD41 T cell trafficking may
e induced by the SIV/HIV envelope itself via CCR5
Weissman et al., 1997).
In vitro, CCR5 appears responsible for most of the
hemotactic activities of the CC chemokine RANTES on
ctivated T cells (Wu et al., 1997a). RANTES is mainly
hemotactic for monocytes and CD41 T memory cells,
lthough CD81 T cell migration toward this chemokine
as also been reported (Murphy et al., 1994; Schall et al.,
990). We detected RANTES mRNA overexpression for
he four monkeys in different tissues from the third week
f infection. Our study therefore suggests the potential of
ymphoid tissues to induce sequestration of circulating
ells as well as the role played by RANTES in leukocyte
rafficking during acute SIV infection. The close link re-
orted between RANTES mRNA expression and in-
reased CD81 T cell percentages in BALMC suggests
hat CD81 lymphocytes are the main source of this che-
okine in BALMC (Conlon et al., 1995). However, several
ther cells including CD41 T cells and macrophages are
lso able to produce this chemokine (Moriuchi et al.,
997b). In this work, we also reported a close in vivo
elationship between IFN-g and RANTES mRNA expres-
ion. This association agrees fully with other studies
howing the induction of RANTES by IFN-g (Chensue et
l., 1997; Marfaing-Koka et al., 1995; Matsukura et al.,
998); however, we are aware that several other factors
ay be involved (Moriuchi et al., 1997b). RANTES and
FN-g concomitant overexpressions argue in favor of the
ole of RANTES in the early immune control of SIV/HIV
nfection. During the first days of SIV infection, RANTES
ay contribute to the local proliferation and activation of
cells, favoring therefore the cytotoxic antiviral response
Dairaghi et al., 1998; Hadida et al., 1998; Taub et al.,
996). In addition, in vitro, RANTES is consistently the
ost effective HIV and SIV suppressor (Cocchi et al., t995; Wang et al., 1998) and has been described to
nhibit HIV-1 replication in human alveolar macrophages
Coffey et al., 1997) and in monocyte-derived macro-
hages (Verani et al., 1997; Wagner et al., 1998). There-
ore, the increased expression of RANTES mRNA after
he peak of high virus load may suggest the contribution
f an early inhibition of HIV/SIV replication in tissues by
his chemokine to the multifactorial control of the overall
iral burden assessed by plasma viral RNA (Lifson et al.,
997).
Our present experiment provides evidence that RAN-
ES and CCR5 responses are included in the broad
mmune activation and the inflammatory state of SIV/HIV
rimary infection. The RANTES and CCR mRNA overex-
ressions that we detected highlight the plurality of che-
okines and their cellular receptor biological effects
ith regard to their implication in viral dissemination and
he development of an efficient antiviral immune re-
ponse during primary infection (Bonecchi et al., 1998;
ottman et al., 1997). Therapy based on a derivative of
ANTES lacking proinflammatory properties as well as
locking cell surface CCR5 expression during the first
ays of HIV infection has been proposed (Arenzana-
eisdedos et al., 1996; Simmons et al., 1997; Yang et al.,
997). Our results underscore the fact that chemokines
nd their receptors operate as part of a delicately bal-
nced network of cytokines and other inflammatory and
mmune mediators: interfering with their functions in vivo
eeds further investigation.
MATERIALS AND METHODS
nimals and virus
Four female cynomolgus monkeys (Macaca fascicu-
aris), weighing 2.5 to 3.5 kg, were imported from Mau-
itius Island for this study. Animals were housed in single
ages within Level 3 biosafety facilities in accordance
ith EC guidelines for primate experiments (“Journal Of-
iciel des Communaute´s Europe´ennes”, L358, december
8, 1986). During handling, the monkeys were always
nesthetized with ketamine (Imalge`ne, Rhoˆne-Me´rieux,
rance). A cell-free pathogenic SIVmac251 stock for in
ivo experiments was kindly provided by Dr. A. M. Au-
ertin (Laboratoire de Virologie, Universite´ Louis Pasteur,
trasbourg, France). Virions were obtained from a cell-
ree supernatant of infected rhesus PBMC. These cells
ere infected in vitro with a culture supernatant obtained
rom a coculture of rhesus PBMC and a spleen homog-
nate from a rhesus macaque infected with SIVmac251
provided by Dr. R. C. Desrosiers, New England Regional
rimate Center, Southborough, MA). Monkeys were in-
culated in the saphenous vein with 4 AID50 (50% animal
nfectious dose). SIVmac251 is a well-known macro-
hage tropic strain (Ringler et al., 1989). We have verifiedhe ability of our primary isolate to replicate in simian
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291RANTES AND CCR5 EXPRESSION DURING ACUTE SIV INFECTIONeripheral monocytes/macrophages as well as alveolar
acrophages (unpublished data).
lood, lymph node, and bronchoalveolar lavage
ample collection
Blood samples were collected for hematological, viro-
ogical, and immunological analyses at 2- to 3-day inter-
als. Peripheral lymph nodes (axillary or inguinal) were
emoved before the experimental inoculation (day 0) and
t 7, 14, and 35 days p.i. PBMC and LNMC were sepa-
ated by standard density gradient centrifugation (MSL,
urobio, Les Ulis, France). BAL was performed after local
nesthesia with lignocaine (Xylovet, Sanofi, France). La-
ages were performed by instilling four to five aliquots of
0 ml of warm 0.9% sterile saline solution through an
ndotracheal tube. The BAL fluids were collected by
mmediate gentle aspiration after each aliquot and
ooled in a sterile heparinate lithium container. Five
ronchoalveolar lavages were performed at weekly in-
ervals before SIV inoculation. After SIV inoculation, la-
ages were done on days 7, 14, 17, 21, 28, and 35 p.i. BAL
amples were centrifuged at 350 g for 10 min. The cells
ere washed with phosphate-buffered saline (PBS) and
ononuclear cells were separated by standard density
radient centrifugation.
etection of circulating virions
SIV RNA levels in plasma samples were measured by
sing the Chiron branched-DNA assay (Chiron Refer-
nce Testing Laboratory, Amsterdam, The Netherlands).
etection of blood infectious cells
The assay for detection of infectious cells in blood was
erformed using isolated PBMC separated by a Ficoll
radient as described previously (Che´ret et al., 1996).
hreefold dilutions of 150,000 monkey cells were cocul-
ivated for 14 days in triplicate in 96-well flat-bottomed
icroplates with 125,000 CEMX174 cells.
etection of anti-SIV IgG in plasma by ELISA
Anti-SIV plasma reactivity was determined as previ-
usly described (Che´ret et al., 1996), using an HIV-2
ntigen detection assay (Elavia II kit; Sanofi Diagnostics
asteur, Marnes-la-Coquette, France).
lymphocyte subset determination
PBMC, LNMC, and BALMC were analyzed by flow
ytometry using a direct immunofluorescence assay to
etermine the percentages of CD41 and CD81 lympho-
ytes. Three hundred thousand cells were maintained at
°C for 30 min with anti-CD4 monoclonal antibody (CD4
eu-3a PE, Becton Dickinson, Mountain View, CA) plus
nti-CD8 monoclonal antibody (CD8 leu-2a FITC, Becton
ickinson) in the same sample or irrelevant isotype- tatched control antibodies (IgG1-FITC, IgG1-PE Immu-
otech, Marseille, France). Cells were then washed two
imes with 2 ml of 3% fetal calf serum in PBS and fixed in
ormaldehyde (CellFIX, Becton Dickinson). The frequency
f each cell subset was calculated using CellQuest soft-
are (Becton Dickinson) on a FACScan cytometer (Bec-
on Dickinson).
T-PCR
The RT-PCR assay was performed as previously de-
cribed (Benveniste et al., 1996) using 2 3 106 fresh
solated monkey PBMC, LNMC, or BALMC. Briefly, cell
ellets were homogenized with 300 ml RNAble (Eurobio,
es Ulis, France) in a 1.5-ml microfuge tube. Thirty mi-
roliters of chloroform was then added. After vigorous
ortexing, the mixture was centrifuged and the aqueous
hase transferred to another microfuge tube containing 3
g yeast tRNA (as a carrier) and an equal volume of
sopropanol. RNA was recovered by 3 h of precipitation
t 220°C and then washed in 70% ethanol. After 1 h of
reatment at room temperature with 10 U RNase-free
Nase (Boehringer GmbH, Mannheim, Germany) in 20
l buffer containing recombinant RNase inhibitor (Clone-
ech, Palo Alto, CA), RNA was subjected to another phe-
ol extraction (Aqua phenol, Appligene, Illkirch, France).
fter vigorous vortexing, the mixture was centrifuged and
he aqueous phase transferred to a microfuge tube con-
aining yeast tRNA and an equal volume of isopropanol.
NA was recovered by overnight precipitation at 4°C and
hen washed in 70% ethanol. Total RNA was subjected to
irst-strand cDNA synthesis for 1 h at 42°C in a 30-ml
eaction volume containing 0.25 M Tris–HCl, pH 8.3,
.375 M KCl, 15 mM MgCl2, 30 U recombinant RNase
nhibitor (Clontech), a 30 mM concentration of each
NTP, 0.3 mg of oligo(dT)12-18 (Sigma, St. Louis, MO), and
50 U Moloney murine leukemia virus reverse transcrip-
ase (Gibco BRL, Grand Island, NY). After completion of
irst-strand synthesis, the reaction mixture was diluted
ith distilled water. Five microliters of this dilution was
sed for each PCR. The PCR mixture (in a volume of 50
l) contained 10 mM of each dNTP, 100 ng of each
pecific primer, buffer as supplied by the manufacturer,
nd 0.5 U Taq polymerase (Appligene, Illkirch, France).
rimer sequences of glyceraldehyde-3-phosphate dehy-
rogenase (GAPDH), IFN-g, RANTES, CCR1, and CCR5
ere GAPDH-59, ACCACCATGGAGAAGGCTGG; GAPDH-39,
TCAGTGTAGCCCAGGATGC, IFN-g-59, ATGAAATATAC-
AGTTATATCTTGGCT, IFN-g-39, GGAATTCACTGGGATG-
TCTTCGACCTCGA; RANTES-59, TCATTGCTACTGCCC-
CTGC; RANTES-39, CGTCGTGGTCAGAATCTGGG; CCR1-59,
CGGATCCCAAAGTCCCTTGGAACCAGAG; CCR1-39, GGT-
TAGACAGGCCACCATTACATTCCCT; CCR5-59, CCTGG-
TGTCGTCCATGCTG; CCR5-39, CTGATCTAGAGCCATG-
GCACAACTCT. PCRs were performed in a Crocodile IIhermocycler (Appligene, Illkirch, France) with denatur-
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292 CHE´RET ET AL.tion at 94°C for 45 s; primer annealing at 58°C for 1 min
or RANTES, 60°C for 2 min for GAPDH and IFN-g, 62°C
or 2 min for CCR1 and CCR5; and extension at 72°C for
min. GAPDH was amplified for 28 cycles, RANTES and
CR1 for 38 cycles, CCR5 for 40 cycles, and IFN-g for 42
ycles. Eight microliters of amplification mixtures was
lectrophoresed on a 1.5% agarose gel and PCR prod-
cts were detected by ethidium bromide staining. The
ignal was quantified using N.I.H. 1.52. (Wayne Rasband
oftware). Results were expressed as the ratio of the
ignal obtained from each cytokine, chemokine, or re-
eptor mRNA to the signal obtained from GAPDH mRNA.
tatistical analysis
The Wilcoxon rank test was used to evaluate the
tatistical significance of circulating CD81 and CD41
ell decreases on day 14 p.i. Absolute numbers of circu-
ating CD41 and CD81 T cells on day 14 p.i. were
ompared to four preinoculation values (Statview; Aba-
us Concept, Berkeley, CA).
The Wilcoxon rank test was used to evaluate the
tatistical significance of the cytokine, chemokine, or
eceptor mRNA/GAPDH mRNA ratio in PBMC or BALMC
n days 7, 14, 17, 21, 28, and 35 p.i. compared to five
reinoculation values (compared to two values for the
BMC ratio of monkey J418) (Statview; Abacus Concept).
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